Sylvaine Cases

Sylvaine Cases has a strong background in business development and strategic partnering within the biotech and pharmaceutical industries. Sylvaine is currently serving as the Chief Business Officer at Appia Bio since 2023. Prior to this, they held the same position at Lynx Biosciences, Inc. from 2021 to 2023. Additionally, from 2021 to 2023, Sylvaine worked as an Independent Business Development Consultant and Interim CBO. Sylvaine also served as the Chief Operating & Business Officer at a VC-backed Stealth IO biotech from 2021 to 2023.

Sylvaine Cases has held significant roles at prominent companies as well. From 2017 to 2020, they worked as the Vice President of Oncology Strategic Partnering at The Janssen Pharmaceutical Companies of Johnson & Johnson. Before that, they held various positions at Sanofi, including Sr Director of Global Business Development and Director of External Innovation.

Earlier in their career, Sylvaine Cases held roles at Arete Therapeutics and Cytokinetics. Sylvaine began their professional journey at Gladstone Institutes as a Post-doctoral fellow and later worked as a Staff Research Scientist.

Sylvaine Cases began their education journey in 1986 when they attended AgroParisTech, where they earned a Master's degree in Bioengineering. From 1989 to 1994, they pursued a Ph.D. in Molecular Oncology at the Institut Gustave Roussy / University Paris Diderot. Finally, from 1995 to 1999, Sylvaine Cases studied at the University of California, San Francisco, but the information does not specify the degree or field of study obtained during this period.